Go BACK

OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 571 - 580 of 692 studies

Oral and Gastrointestinal

A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Subjects Diagnosed With Epilepsy (XPF-010-304 (X-TOLE4))

Early Risk Stratification by Lymph Liquid Biopsy in Malignant Melanoma and Breast Cancer

Assessing the clinical benefits of whole genome sequencing for children with neoplasms

Investigating the use of structured light plethysmography to diagnose breathing pattern disorder in patients with unexplained breathlessness

Neurological

A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of SRP 9001 in Non-Ambulatory and Ambulatory Subjects With Duchenne Muscular Dystrophy (ENVISION)

Cancer and neoplasms

Phase 3, Open-Label, Randomized Study of Neoadjuvant Datopotamab Deruxtecan with Durvalumab +/- Chemotherapy followed by Adjuvant Durvalumab, Versus Neoadjuvant Pembrolizumab + Chemotherapy and Adjuvant Pembrolizumab, in Patients with Stage II-III Triple Negative Breast Cancer (TROPION-Breast04)

Development of an intra-operative mass-spectrometry tool for real-time tissue analysis during brain tumour biopsy and resection surgery

Oxford Translational Myeloma Centre Biobank

Biomarkers for individualised treatment response in amyotrophic lateral sclerosis (ITERALS)

Cancer and neoplasms

New title: A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study to Determine the Safety and Efficacy of BGB-11417 as Monotherapy, in Combination With Dexamethasone, Dexamethasone/Carfilzomib, Dexamethasone/Daratumumab, and Dexamethasone/Pomalidomide in Patients With Relapsed/Refractory Multiple Myeloma and t(11;14) (Pilot 105)